Trial · NCT07902167
Evaluating the Efficacy and Safety of a New Laparoscopic Non-mesh Hernia Needle Set Designed for Indirect Inguinal Hernia
NCT07902167, Not applicable, Active not recruiting, Chang Gung Memorial Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Evaluating the Efficacy and Safety of a New Laparoscopic Non-mesh Hernia Needle Set Designed for Indirect Inguinal Hernia. Trials, record NCT07902167. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07902167
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Evaluating the Efficacy and Safety of a New Laparoscopic Non-mesh Hernia Needle Set Designed for Indirect Inguinal Hernia
- NCT number
- NCT07902167
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 96 participants, estimated
- Lead sponsor
- Chang Gung Memorial Hospital
- Conditions
- Inguinal Hernia, Without Mention of Obstruction or Gangrene
- Interventions
- non-mesh inguinal hernia needle, conventional needle set
- First posted
- 2026-10-28
- Last updated
- 2026-10-28
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | post operational pain | From enrollment to the end of treatment at 24 weeks | Evaluated by Mankoski Pain Scale (score 0-10, zero is equivalent to no pain and 10 indicates the worst possible pain) on the operation day and one week after surgery, and recording frequency and kinds of analgesics used after surgery by charts |
| Secondary | Operation time | During the surgery | The operation time, measured in minutes, is defined as the time elapsed from insertion of the trocar through the umbilicus to its removal from the umbilicus at the end of the operation. |
| Secondary | Time to resumption of daily activities | From enrollment to the end of treatment at 24 weeks | The number of days from surgery until the patient resumes usual daily activities, including work, exercise, and household activities. |
| Secondary | Ipsilateral inguinal hernia recurrence rate within six months after surgery | From enrollment to the end of treatment at 24 weeks | The proportion of patients who develop recurrent inguinal hernia on the operated side within six months after surgery. The recurrence rate will be calculated as the number of patients with recurrence divided by the total number of patients evaluated for recurrence, multiplied by 100%. |
| Secondary | Wound infection rate | From enrollment to the end of treatment at 24 weeks | The proportion of patients who develop a surgical wound infection following surgery during the prespecified follow-up period. The wound infection rate will be calculated as the number of patients with a wound infection divided by the total number of patients evaluated for wound infection, multiplied by 100%. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07902167
GET https://conductscience.org/api/trials/v1/NCT07902167/registered